SOMERSET, N.J., May 8, 2024 /PRNewswire/ -- Retired New Jersey
Marine Robert Hanley became the 7,000th patient to complete
treatment at ProCure Proton Therapy Center, surpassing a major
milestone at the tri-state region's original proton therapy
facility.
Hanley was diagnosed with lung cancer in August 2023. His doctors at the VA originally
recommended chemotherapy and traditional radiation, but they were
concerned about the impact on his heart. His doctors turned to
ProCure and proton therapy, in part because it could effectively
address his cancer while reducing radiation exposure by up to 50%
compared to standard X-ray radiation.
Standard X-ray radiation releases its maximum dose and continues
to release it as it passes and exits through the body beyond the
tumor. By contrast, proton therapy releases its maximum dose
directly within the tumor and then stops, sparing nearby organs
such as the heart.
Additionally, patients often experience fewer side effects both
during and after treatment with proton therapy versus traditional
radiation.
"ProCure gave me the chance to feel like myself again," Hanley
said. "Thanks to this treatment and my amazing doctor and nurses, I
am hopeful to be on a path to recovery."
"On behalf of the entire ProCure team, we want to thank Mr.
Hanley for his service and dedication to our country," said
Tom Wang, President of ProCure. "As
a cancer patient and retired Marine, he exemplifies the core values
of honor and courage. We are inspired that he put his trust in our
team."
ProCure, located in nearby Somerset,
NJ, treats a range of cancers, including diseases of the
prostate, breast, lung, brain, head and neck, and gastrointestinal
system, as well as sarcomas and many pediatric cases.
"We are honored to have impacted 7,000 lives and counting," said
Dr. Brian Chon, ProCure's Medical
Director, who treated Hanley. "Each patient's journey is a
testament to our commitment to excellence and the transformative
power of proton therapy. Our dedicated team at ProCure remains
steadfast in our mission to provide exceptional care and innovative
treatment options to those battling cancer."
Added Wang: "Surpassing this milestone has taken an extremely
skilled care team, professional support team, and partnerships at
area institutions that have collaborated with us throughout our
journey. We are grateful to everyone who has contributed to these
life-changing treatments and we look forward to continued
innovation so we can serve patients for decades to come."
About ProCure Proton Therapy Center:
ProCure Proton Therapy Center in Somerset, NJ, opened in March 2012 as the tri-state region's first proton
therapy facility, treating a range of cancers including diseases of
the prostate, breast, lung, brain, head and neck, and
gastrointestinal system, as well as sarcomas and many pediatric
cases. Using the most advanced radiation treatment available,
ProCure has treated more than 7,000 patients overall, including
750+ pediatric patients coming from the U.S. and abroad, and
enables many cancer patients to choose a non-surgical treatment
personalized to their medical needs and lifestyles, often with
fewer side effects and less downtime—giving them more freedom to
enjoy what matters most in their lives. For more information, visit
ProCure.com.
Media Contact:
Sarah
Ferrington, Marketing Manager
Phone: 732-357-2609
Email: sarah.ferrington@procure.com
View original
content:https://www.prnewswire.com/news-releases/new-jersey-marine-becomes-procures-7-000th-patient-to-complete-cancer-treatment-302140361.html
SOURCE ProCure Proton Therapy Center